CANNAPHARMARX, INC. (CPMD)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, CANNAPHARMARX, INC. reported revenue of $1.36M, up 66.1% from the prior year. The company ran a net loss, with a net margin of -817.2% and a gross margin of -153.1%. It held $7.02M in total assets against $37.17M in total liabilities.
Key ratios (FY2025)
-153.1%
Gross margin
-245.8%
Operating margin
-817.2%
Net margin
+66.1%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.36M | $820.1K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cost of Revenue | $3.45M | $3.76M | $0 | — | — | — | — | — | — | — |
| Gross Profit | -$2.08M | -$2.93M | $0 | — | — | — | — | — | — | — |
| Operating Income | -$3.35M | -$3.63M | -$1.58M | -$5.21M | -$2.99M | -$14.49M | -$15.98M | -$954.3K | -$6.6K | -$1.00M |
| Net Income | -$11.13M | -$9.91M | $3.69M | -$8.53M | -$8.83M | -$19.89M | -$20.45M | -$3.09M | -$6.6K | -$1.00M |
| EPS (Diluted) | $-0.02 | $-0.02 | $0.01 | $0.04 | $0.12 | — | — | — | — | — |
| Total Assets | $7.02M | $10.84M | $11.75M | $5.41M | $114.3K | $8.75M | $16.02M | $10.10M | $0 | $1.7K |
| Total Liabilities | $37.17M | $30.65M | $23.90M | $22.76M | $13.04M | $17.55M | $11.16M | $10.38M | $964.3K | $959.3K |
| Shareholders' Equity | -$30.15M | -$19.81M | -$12.15M | $17.34M | -$12.93M | -$8.80M | $4.85M | -$286.3K | -$964.3K | -$957.7K |
| Cash & Equivalents | $1.8K | $2.2K | $650 | $2.3K | $27.8K | $335.0K | $1.5K | $464.1K | $0 | $0 |
| Operating Cash Flow | -$789.1K | -$1.70M | -$2.27M | -$1.45M | -$2.41M | -$563.6K | -$3.79M | -$941.1K | $0 | -$22.4K |
| Capital Expenditures | $5.5K | $0 | $80.6K | — | — | — | $4.8K | $0 | — | $0 |
| Shares Outstanding | 662.50M | 662.50M | 440.75M | 274.12M | 125.51M | 46.99M | 36.49M | 18.94M | 17.96M | 17.96M |